BHCM
EDIT icon

Brevan Howard Capital Management’s Editas Medicine EDIT Stock Holding History

Brevan Howard Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.5K Buy
+14,359
New +$42K ﹤0.01% 2019
2024
Q4 		– Sell
-30,116
Closed -$103K – 1140
2024
Q3 		$103K Sell
30,116
-48,952
-62% -$213K ﹤0.01% 1074
2024
Q2 		$369K Buy
+79,068
New +$446K ﹤0.01% 710
2021
Q3 		– Sell
-47,176
Closed -$2.67M – 41
2021
Q2 		$2.67M Hold
47,176
– – 0.73% 25
2021
Q1 		$1.98M Sell
47,176
-29,244
-38% -$1.67M 0.29% 41
2020
Q4 		$5.36M Buy
+76,420
New +$3.14M 1.07% 18

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Brevan Howard Capital Management's EDIT Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Editas Medicine (EDIT) in Q2 2026: 14,359 shares worth $46.5K. The stake represents ﹤0.01% of the portfolio and ranks #2019 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in EDIT as recently as Q3 2024.

Brevan Howard Capital Management first reported a position in EDIT in Q4 2020 and has held it in 6 quarters since. The position peaked at $5.36M in Q4 2020. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Brevan Howard Capital Management held 14,359 shares of Editas Medicine worth $46.5K as of Q2 2026.
  • Editas Medicine was a new Brevan Howard Capital Management position in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #2019 holding.
  • Brevan Howard Capital Management first reported a position in Editas Medicine in Q4 2020 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Editas Medicine position peaked at $5.36M in Q4 2020.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.